Kristin Palmsten1, Katharine K Nelson2, Louise C Laurent3, Soojin Park3, Christina D Chambers4, Mana M Parast2. 1. HealthPartners Institute, Mail Stop: 23301A, P.O. Box 1524, Minneapolis, MN, 55440, United States; Department of Pediatrics, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, United States. Electronic address: kristin.k.palmsten@healthpartners.com. 2. Department of Pathology, University of California San Diego, La Jolla, 9500 Gilman Drive, La Jolla, CA, 92093, United States; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA, 92093, United States. 3. Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA, 92093, United States; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, United States. 4. Department of Pediatrics, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, United States; Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, 9500 Gilman Drive, La Jolla, CA, 92093, United States.
Abstract
OBJECTIVE: To evaluate the association between subclinical and clinical chorioamnionitis and risk of preterm birth (PTB). METHODS: Demographic and clinical characteristics were abstracted from medical records and placental examinations performed (N = 1371 pregnancies including spontaneous and medically-indicated PTBs). Pregnancies were classified as having clinical chorioamnionitis (with or without histologic chorioamnionitis), subclinical chorioamnionitis (histologic, but not clinical, chorioamnionitis), or no chorioamnionitis; pregnancies with histologic chorioamnionitis were further evaluated for fetal vasculitis. Relative risks for PTB, early and late PTB, and PTB ± premature rupture of membranes (PROM) were adjusted for maternal characteristics. RESULTS: Clinical (4.3%) and subclinical (24.5%) chorioamnionitis were not associated with PTB overall. In pregnancies without clinical or subclinical chorioamnionitis, the risk of PTB with PROM and early PTB was 2.2% and 8.6%, respectively. In comparison, clinical chorioamnionitis was associated with an increased risk of PTB with PROM (aRR: 3.42 (95%CI: 1.07, 10.98), whereas subclinical chorioamnionitis was associated with increased risk of PTB with PROM (aRR: 3.92 (95% CI: 2.15, 7.12)) and early PTB (aRR: 1.77 (95% CI: 1.18, 2.64)). Histologic chorioamnionitis with fetal vasculitis was associated with increased risk of PTB with PROM (aRR: 7.44 (95% CI: 3.68, 15.05)) and early PTB (aRR: 2.94 (95% CI: 1.78, 4.87)), whereas histologic chorioamnionitis without fetal vasculitis was associated with increased risk of PTB with PROM only (aRR: 2.64, 95% CI: 1.27, 5.50). CONCLUSIONS: Subclinical chorioamnionitis and histologic chorioamnionitis with fetal vasculitis were associated with early PTB and PTB with PROM but not with PTB overall, likely due to inclusion of indicated PTBs.
OBJECTIVE: To evaluate the association between subclinical and clinical chorioamnionitis and risk of preterm birth (PTB). METHODS: Demographic and clinical characteristics were abstracted from medical records and placental examinations performed (N = 1371 pregnancies including spontaneous and medically-indicated PTBs). Pregnancies were classified as having clinical chorioamnionitis (with or without histologic chorioamnionitis), subclinical chorioamnionitis (histologic, but not clinical, chorioamnionitis), or no chorioamnionitis; pregnancies with histologic chorioamnionitis were further evaluated for fetal vasculitis. Relative risks for PTB, early and late PTB, and PTB ± premature rupture of membranes (PROM) were adjusted for maternal characteristics. RESULTS: Clinical (4.3%) and subclinical (24.5%) chorioamnionitis were not associated with PTB overall. In pregnancies without clinical or subclinical chorioamnionitis, the risk of PTB with PROM and early PTB was 2.2% and 8.6%, respectively. In comparison, clinical chorioamnionitis was associated with an increased risk of PTB with PROM (aRR: 3.42 (95%CI: 1.07, 10.98), whereas subclinical chorioamnionitis was associated with increased risk of PTB with PROM (aRR: 3.92 (95% CI: 2.15, 7.12)) and early PTB (aRR: 1.77 (95% CI: 1.18, 2.64)). Histologic chorioamnionitis with fetal vasculitis was associated with increased risk of PTB with PROM (aRR: 7.44 (95% CI: 3.68, 15.05)) and early PTB (aRR: 2.94 (95% CI: 1.78, 4.87)), whereas histologic chorioamnionitis without fetal vasculitis was associated with increased risk of PTB with PROM only (aRR: 2.64, 95% CI: 1.27, 5.50). CONCLUSIONS:Subclinical chorioamnionitis and histologic chorioamnionitis with fetal vasculitis were associated with early PTB and PTB with PROM but not with PTB overall, likely due to inclusion of indicated PTBs.
Authors: Michael S Kramer; Aris Papageorghiou; Jennifer Culhane; Zulfiqar Bhutta; Robert L Goldenberg; Michael Gravett; Jay D Iams; Agustin Conde-Agudelo; Sarah Waller; Fernando Barros; Hannah Knight; Jose Villar Journal: Am J Obstet Gynecol Date: 2011-10-25 Impact factor: 8.661
Authors: Jose Villar; Aris T Papageorghiou; Hannah E Knight; Michael G Gravett; Jay Iams; Sarah A Waller; Michael Kramer; Jennifer F Culhane; Fernando C Barros; Agustín Conde-Agudelo; Zulfiqar A Bhutta; Robert L Goldenberg Journal: Am J Obstet Gynecol Date: 2011-10-25 Impact factor: 8.661
Authors: Karen M Chisholm; Amy Heerema-McKenney; Lu Tian; Anand K Rajani; Suchi Saria; Daphne Koller; Anna A Penn Journal: Placenta Date: 2016-01-16 Impact factor: 3.481
Authors: Amy G Brown; Monique E Maubert; Lauren Anton; Laura M Heiser; Michal A Elovitz Journal: Am J Reprod Immunol Date: 2019-09-30 Impact factor: 3.886